期刊文献+

复方苦参注射液对结直肠癌患者化疗相关不良反应的临床观察

Clinical Fufangkushen injection of chemotherapy-related adverse effects on patients of colorectal cancer
下载PDF
导出
摘要 目的观察复方苦参注射液对结、直肠癌患者化疗相关不良反应的影响。方法选取术后辅助化疗的结直肠癌患者78例,随机分成试验组(A)及对照组(B),A组在化疗中联合复方苦参注射液治疗,观察分析两组化疗相关不良反应的情况。结果 A组消化道反应的发生明显较B组延迟,发生率及反应程度明显较B组低;A组骨髓抑制的发生较B组推迟,发生率及抑制程度较B组偏低;A组的体力状态较B组强;A组生活质量较B组高。结论复方苦参注射液联合化疗时,可减轻化疗相关的消化道不良反应;增强患者的免疫功能、提高患者体力状态、改善患者的生存质量。 Objective To observe the Fufangkushen injection of chemotherapy-related adverse effects on patients with colorectal cancer.Methods I Division 1.2015- Patients with colorectal cancer in September adjuvant chemotherapy were treated 78 patients were randomly divided into experimental group(A) and control group(B),A set of conjoined Fufangkushen injection in the treatment of chemotherapy on the basis of group B.Results 1.The gastrointestinal reaction of group A than group B delays,the incidence and reaction was significantly lower than group B;2.A group of bone marrow suppression of delay in the B group,the incidence and degree of inhibition compared with group B is low;3.The physical state of A group was obviously compared with group B;4.The quality of life of group A is significantly higher than group B.Conclusion the study found that compound sophora injection chemotherapy,can reduce the related gastrointestinal adverse reaction of chemotherapy.Enhance the immunity of the patients and improve the patients' physical condition,improve survival quality of patients.
作者 孔研 谢晓冬
出处 《环球中医药》 CAS 2015年第S2期67-68,共2页 Global Traditional Chinese Medicine
关键词 苦参注射液 结直肠癌 化疗反应 观察 Fufangkushen injection Colorectal cancer Chemotherapy Toxicity
  • 相关文献

参考文献4

  • 1陈翠,李宇红.结直肠癌肝转移围手术期的治疗进展[J].临床肿瘤学杂志,2013,18(5):468-471. 被引量:4
  • 2宣丽君.复方苦参注射液在化疗中的作用评价[J].药学进展,2005,29(5):227-229. 被引量:48
  • 3Lavinia Fiorentino,Michelle Rissling,Lianqi Liu,Sonia Ancoli-Israel.??The symptom cluster of sleep, fatigue and depressive symptoms in breast cancer patients: severity of the problem and treatment options(J)Drug Discovery Today: Disease Models . 2011 (4)
  • 4Trotti Andy,Bentzen Soren M.The need for adverse effects reporting standards in oncology clinical trials. Journal of clinical oncology : official journal of the American Society of Clinical Oncology . 2003

二级参考文献29

  • 1孙燕.临床肿瘤内科手册(第三版)[M].北京:人民卫生出版社,1991.23-26.
  • 2Fong Y, Fortner J, Sun RL, et al. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases [J]. Ann Surg, 1999,230 ( 3 ) : 309-318, 318-321.
  • 3Kattan MW, Gfnen M, Jarnagin WR,et al. A nomogram for predicting disease-specific survival afier hepatic resection for meta- static colorectal cancer [ J ]. Ann Surg,2008,247 ( 2 ) :282 - 287.
  • 4Beppu T, Sakamoto Y, Hasegawa K, et al. A nomogram predicting disease-free survival in patients with eoloreetal liver metasta- ses treated with hepatic resection: muhicenter data collection as a Project Study for Hepatic Surgery of the Japanese Society of Hepato-Biliary-Pancreatic Surgery [ J ]. J Hepatobiliary Pancreat Sci, 2012,19(I) :72 -84.
  • 5Mitry E, Fields AL, Bleiberg H, et al. Adjuvant chemotherapy after potentially curative resection of metastases from colorectal cancer: a pooled analysis of two randomized trials [ J ]. J Clin Oncol,2008,26 (30) :4906 -4911.
  • 6Portier G, Elias D, Bouche O, et al. Muhicenter randomized trial of adjuvant fluorouracil and folinic acid compared with surgery a- lone after resection of colorectal liver metastases : FFCD ACHBTH AURC 9002 trial[J]. J Clin Oncol,2006,24(31 ) :4976 -4982.
  • 7Mitry E, Fields AL, Bleiberg H, et al. Adjuvant chemotherapy after potentially curative resection of metastases from colorectal cancer: a pooled analysis of two randomized trials[J]. J Clin Oncol, 2008,26 ( 30 ) :4906 - 4911.
  • 8Ychou M, Hohenberger W, Thezenas S, et al. A randomized phase Ⅲ study comparing adjuvant 5-fluorouracil/folinic acid with FOLFIRI in patients following complete resection of liver metastases from colorectal cancer[ J]. Ann Oncol,2009,20 (12) :1964 - 1970.
  • 9Kanemitsu Y, Kato T, Shimizu Y, et al. A randomized phase Ⅱ/Ⅲ trial comparing hepatectomy followed by mFOLFOX6 with hepatectomy alone as treatment for liver metastasis from colorectal cancer: Japan Clinical Oncology Group Study JCOG0603 [ J]. Jpn J Clin Oncol,2009,39(6) :406 -409.
  • 10Kim SY, Kim H J, Hong YS, et al. Resected colorectal liver metastases : Does the survival differ according to postoperative chemotherapy regimen ? [J]. J Surg Oncol,2009, ! 00 ( 8 ) : 713 - 718.

共引文献51

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部